Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Breadcrumb
Home
Evidence
WITN3496017 - Written Statement of Professor Gordon Lowe - 05 Oct 2022
WITN3496017 - Written Statement of Professor Gordon Lowe - 05 Oct 2022
Documents
5 October 2022
WITN3496017 Written Statement of Professor Gordon Lowe 05 Oct 2022
5 October 2022
WITN3496018 Letter from North Glasgow University Hospital to W2245 regarding Haemophilia treatments and vCJD important information 20 Sep 2004
5 October 2022
WITN3496022 Letter from Haemophilia Centre Co Directors to W2245 01 Feb 2009
5 October 2022
WITN3496021 Pending procedure notification for W2245 20 Mar 2008
5 October 2022
WITN3496020 Patient VCJD Exposure assessment form 09 Nov 2004
5 October 2022
WITN3496019 Variant Creutzfeldt Jakob Disease and Plasma Products Patient Reply Sheet 22 Sep 2004
Evidence Information
Date
5 October 2022
Witness
Professor Gordon Lowe
View other evidence